• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Fibromyalgia Affects About One in Ten Women with Chronic Pelvic Pain, Review Finds

by
October 29, 2026
in Health
Reading Time: 3 mins read
0
Fibromyalgia Affects About One in Ten Women with Chronic Pelvic Pain, Review Finds

Fibromyalgia Affects About One in Ten Women with Chronic Pelvic Pain, Review Finds

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A systematic review and meta-analysis published in Advances in Rheumatology on 10 September 2026 estimates that fibromyalgia affects roughly one in ten women with chronic pelvic pain, with a pooled prevalence of 9.0% after random-effects adjustment and a raw mean of 10.3% across the included studies. The work was registered in PROSPERO (CRD420251142371) and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

The research team searched eight databases without time restrictions, including observational studies and clinical trials of women aged 13 years or older with chronic pelvic pain that reported fibromyalgia prevalence. Ten studies met the criteria, together encompassing 52,658 participants. Most of the evidence came from the United States, and the studies were predominantly cross-sectional designs and retrospective cohorts. Statistical analysis used a random-effects model in R software, with heterogeneity assessed through Cochran’s Q and Higgins’ I² statistics.

The headline number conceals a strikingly wide range. Reported prevalence across the included studies spanned from 2% to 16%, and the authors attribute this spread to differences in the populations studied, the pain phenotypes involved, and the diagnostic methods used to identify fibromyalgia. Statistical heterogeneity was high, with an I² of 91.4%, meaning that only a small fraction of the variation between studies can be explained by chance alone rather than by real differences in methods and participants.

That heterogeneity shapes how the findings should be read. The authors conclude that the available evidence suggests a potential overlap between fibromyalgia and chronic pelvic pain, particularly in some urological pelvic pain populations, but they caution that substantial clinical and methodological heterogeneity limits the generalizability of the results, which should be interpreted cautiously. In practical terms, the pooled 9.0% figure is best understood as a summary of a varied body of observational research rather than a single precise estimate applicable to every clinical setting.

The review also set out to map the associated conditions that have been investigated alongside fibromyalgia in this population, reflecting a broader research interest in how chronic pelvic pain coexists with other pain conditions. Because the included studies were observational or trial-based prevalence reports rather than controlled comparisons, the analysis establishes how often the two conditions occur together in the studied groups; it does not establish that one condition causes the other. The predominance of US-based, cross-sectional and retrospective data further limits what can be said about other regions and about incidence over time.

The authors emphasize, however, that the reported prevalence range reflected differences in population, pain phenotype, and diagnostic methods, and they caution that the findings should be interpreted cautiously. The article was published as open access, and the version shared early is citable with a permanent DOI while remaining subject to further editorial edits before the final Version of Record.

Subject of Research: The prevalence of fibromyalgia among women with chronic pelvic pain, assessed through a systematic review and meta-analysis.

Article Title: Prevalence of fibromyalgia in women with chronic pelvic pain: a systematic review and meta-analysis

Article References: Silva, A. F. D., Nogueira Neto, J., Soares, M. L., Silva, A. L. S. D., Silva Junior, A. F. D., Silva, A. L. S. D., Álvares, L. G. G. S., Velozo, A. C. S., Gomes, L. M. R. D. S., & Leal, P. D. C. (2026). Prevalence of fibromyalgia in women with chronic pelvic pain: a systematic review and meta-analysis. Advances in Rheumatology. https://doi.org/10.1186/s42358-026-00573-9

Image Credits: AI Generated

DOI: 10.1186/s42358-026-00573-9

Keywords: fibromyalgia, chronic pelvic pain, systematic review, meta-analysis, prevalence, women's health, rheumatology, heterogeneity, observational studies, pain research, women, chronic

News Source: Ophelia Keating. (October 29, 2026). Fibromyalgia Affects About One in Ten Women with Chronic Pelvic Pain, Review Finds. Scienmag.

Tags: chronicchronic pelvic painfibromyalgiaheterogeneityMeta-analysisobservational studiespain researchprevalencerheumatologysystematic reviewwomenwomen's health
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.